
Motus GI Investor Relations Material
Latest events

Q3 2022
Motus GI

Q1 2024
14 May, 2024

Q4 2023
18 Mar, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Motus GI Holdings Inc
Access all reports
Motus GI Holdings, Inc. is a medical technology company specializing in the development of solutions to enhance the effectiveness of colonoscopy procedures. The company’s flagship product is a system designed to improve visualization during colonoscopies by facilitating the removal of bowel contents, which helps in detecting abnormalities and reduces the need for repeat procedures. Motus GI primarily serves healthcare providers and aims to improve patient outcomes and procedural efficiency in gastrointestinal care. The company is headquartered in Fort Lauderdale, United States, and its shares are listed on the NASDAQ.
Latest articles
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
)
Costco Wholesale: The Model of Scalable Simplicity
Costco's rise from warehouse club to retail giant is built on low prices, scale efficiency, and a model designed for lasting customer value.
26 May 2025
Ticker symbol
MOTS
Country
🇺🇸 United States